JPH0366604A - Dermal cosmetic - Google Patents

Dermal cosmetic

Info

Publication number
JPH0366604A
JPH0366604A JP20366989A JP20366989A JPH0366604A JP H0366604 A JPH0366604 A JP H0366604A JP 20366989 A JP20366989 A JP 20366989A JP 20366989 A JP20366989 A JP 20366989A JP H0366604 A JPH0366604 A JP H0366604A
Authority
JP
Japan
Prior art keywords
skin
formula
ceramide
cosmetic
dermal cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20366989A
Other languages
Japanese (ja)
Inventor
Ryoichi Uchida
良一 内田
Mitsuo Kondo
光男 近藤
Hiroshi Togiya
研谷 啓
Tadatake Ogawa
小川 忠丈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP20366989A priority Critical patent/JPH0366604A/en
Publication of JPH0366604A publication Critical patent/JPH0366604A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain a dermal cosmetic enhancing water-retentive function of skin, keeping skin in healthy state and exhibiting beauty skin action containing monoacyl-type phospholipid and a compound selected from ceramide, glucosyl ceramide and galactosyl ceramide. CONSTITUTION:The aimed dermal cosmetic contains respectively 0.01-5wt.% a compound expressed by formula I or formula II (R is -CO-C17H35 or -CO-C15H31; X is group expressed by formula III or formula IV, etc.) and at least a species selected from ceramide, glucosyl ceramide and galactosyl ceramide. 1-palmitoyl-3-glyceryl phosphorylcholine and 2-palmitoyl-3-glyceryl phosphorylcholine, etc., are exemplified as the compounds expressed by formula I and formula II. Said dermal cosmetic densifies structure of horny layer in exhibiting strong affinity with said layer and exhibits excellent improving effect of rough skin by enhancing humidity-retentive function with controlling water- retentive property inside of skin.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、皮膚化粧料に関し、特にモノアシル型リン脂
質およびセラミド、グルコシルセラミド。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to skin cosmetics, particularly monoacyl phospholipids, ceramides, and glucosylceramides.

ガラクトシルセラミドより選ばれた少なくとも一種を組
合せて含む皮膚化粧料に関する。
The present invention relates to a skin cosmetic containing a combination of at least one selected from galactosylceramide.

〔従来の技術および発明が解決しようとする課題〕[Problems to be solved by conventional technology and invention]

従来より、健常な皮膚を保持する為に、皮膚に適度な水
分と油分を与える親水性の皮膚保湿剤と油性の皮膚柔軟
剤とを皮膚化粧料に配合することが行われている。
BACKGROUND ART Conventionally, in order to maintain healthy skin, a hydrophilic skin moisturizer and an oily skin softener that provide appropriate moisture and oil content to the skin have been blended into skin cosmetics.

皮膚保湿剤には、グリセリン、プロピレングリコール、
ポリエチレングリコール、ピロリドンカルボン酸塩等が
利用されているが、これらは、皮膚の最外層である角質
層の水分を吸水して、かえって皮膚の水分を損失する原
因となることがあり、また、多量に含有する皮膚化粧料
にあっては、べたつくなどの違和感を与えるなど、必ず
しも満足出来るものではなかった。
Skin moisturizers include glycerin, propylene glycol,
Polyethylene glycol, pyrrolidone carboxylate, etc. are used, but these may absorb water from the stratum corneum, the outermost layer of the skin, causing moisture loss in the skin, and they may also cause large amounts of water to be lost. However, skin cosmetics containing such substances have not always been satisfactory, as they give an uncomfortable feeling such as stickiness.

また、皮膚柔軟剤には、流動パラフィン、ワセリン、オ
リーブ油、スクアラン、ラノリン、合成エステル油等が
利用されているが、これらも、表皮よりの水分蒸散を充
分に防ぐ程度に皮膚化粧料に含有せしめるときには、皮
膚の正常なる新陳代謝を阻害する原因となるなどの欠点
を有していた。
In addition, liquid paraffin, petrolatum, olive oil, squalane, lanolin, synthetic ester oil, etc. are used as skin softeners, but these are also included in skin cosmetics to the extent that they sufficiently prevent water evaporation from the epidermis. In some cases, they have the disadvantage of interfering with the normal metabolism of the skin.

皮膚を始めとする生体&l繊織中存在することが知られ
ているセラミド類の化粧料への応用に関しては、特開昭
61−260008号公報、特開昭61−271205
号公報などに示される皮膚化粧料があるが、化粧料用の
組成物として、これらの成分を単独で皮膚に適用したと
しても皮膚の水分保持機能を亢進させることは未だ充分
ではない。
Regarding the application of ceramides, which are known to exist in living bodies and textiles including the skin, to cosmetics, please refer to JP-A-61-260008 and JP-A-61-271205.
Although there are skin cosmetics disclosed in Japanese Patent Publication No. 2003-120003, even if these components are applied alone to the skin as a cosmetic composition, they are still not sufficient to enhance the moisture retention function of the skin.

また、モノアシル型リン脂質は生体膜親和性に冨む両親
媒性物質であることが知られているが、最近では特開昭
61−171407号公報、特開昭61−186305
号公報、特開昭61210016号公報にみられるよう
に乳化剤として皮膚化粧料の基剤として応用されている
Furthermore, monoacyl phospholipids are known to be amphipathic substances with a high affinity for biomembranes, and recently they have been published in Japanese Patent Application Laid-Open Nos. 61-171407 and 61-186305.
As shown in Japanese Patent Application Laid-Open No. 61210016, it is used as an emulsifier and a base for skin cosmetics.

〔課題を解決するための手段〕[Means to solve the problem]

本発明者等は、皮膚保湿剤、皮膚柔軟剤にみられる上記
の欠点に鑑み、それら配合剤の物理的作用による表皮へ
の水分補給あるいは表皮よりの水分蒸散防止のみに依存
するのではなく、皮膚が本来備えている水分保持機能を
亢進することによって皮膚を健常な状態に保持し、ある
いは修復するような皮膚化粧料を提供することを目的と
して鋭意研究した。
In view of the above-mentioned drawbacks of skin moisturizers and emollients, the present inventors do not rely solely on the physical action of these ingredients to replenish moisture to the epidermis or prevent water evaporation from the epidermis. We conducted extensive research with the aim of providing skin cosmetics that maintain or repair the skin in a healthy state by enhancing the skin's inherent moisture retention function.

即ち、皮膚の水分は、真皮から表皮の基底細胞層、更に
角質層へと外層に向うにつれて減少する水分含量の勾配
に沿って、常に皮膚内部から外層部へ移動し、角質層を
通じて外部へ蒸散しているが、この水分蒸散は主に顆粒
層頂部の層板顆粒から角質層に及び緻密な細胞&llI
織からなる防御機能(バリヤー機能〉により制御されて
おり、工亥蒸散健常な皮膚の正常な状態における前腕部
皮表では0、2〜0.3 m g / c m ” /
 h rの範囲、通常は0、25 m g / c m
 ” / h r程度以下に保持されている。これに対
して、通常にみられる乾燥皮膚(ドライスキン)あるい
は老化皮膚にみられる乾燥皮膚では、その程度に応じて
T W L (iは上記の範囲の上限値もしくはそれよ
り大きな値を示し、皮膚の水分保持機能が低下している
ことが認められる。これはそれら乾燥皮膚の場合、角質
層の防御機能による通常の制御限界を超えた状態にある
か、あるいは該防御機能が衰えていることに由来するも
のである。
In other words, water in the skin constantly moves from the inside of the skin to the outer layer along a gradient of water content that decreases as it goes from the dermis to the basal cell layer of the epidermis and then to the stratum corneum, and evaporates to the outside through the stratum corneum. However, this water evaporation mainly occurs from the lamellar granules at the top of the granular layer to the stratum corneum, and from the dense cells &llI
It is controlled by the protective function (barrier function) consisting of the skin, and the amount of transpiration in healthy skin is 0.2 to 0.3 mg/cm''/cm on the skin surface of the forearm under normal conditions.
h r range, typically 0, 25 m g/cm
”/hr.On the other hand, in the case of normal dry skin (dry skin) or dry skin seen in aging skin, T W L (i is the above) depending on the degree of dry skin. The value is at or above the upper limit of the range, indicating a decline in the skin's ability to retain moisture. This may be due to the fact that the defense function is weakened.

従って、角質層及び層板顆粒の組織を緻密化することか
できれば、これによって皮膚の水分保持機能が亢進され
、皮膚は健常な状態に保持されると共に、更に乾燥皮膚
の改善ないしは修復が可能となる。
Therefore, if the structure of the stratum corneum and lamellar granules can be densified, the moisture retention function of the skin will be enhanced, the skin will be maintained in a healthy state, and dry skin can be improved or repaired. Become.

そこで、本発明者等は、皮膚の水分保持機能を亢進させ
る作用を持つセラミド、グルコシルセラミド、ガラクト
シルセラミドと生体膜親和性に冨むモノアシル型リン脂
質の人皮膚に対する作用効果に関して鋭意研究した結果
、セラミド、グルコシルセラミド、ガラクトシルセラく
ド類とモノアシル型リン脂質を化粧料中に同時に配合し
、皮膚に通用した時には、セラミド、グルコシルセラ旦
ド、ガラクトシルセラξド類を単独で用いた場合に比べ
皮膚の表面及び皮膚の最外層である角質層に強い親和性
を示し、それらの構造を緻密化し、皮膚内部の水分81
能を調節し、皮膚の保温機能を亢進させ荒れ肌を改善す
る効果が高いことを見出した。
Therefore, the present inventors conducted extensive research on the effects on human skin of ceramide, glucosylceramide, and galactosylceramide, which have the effect of enhancing the moisture retention function of the skin, and of monoacyl-type phospholipids, which are rich in biomembrane affinity. When ceramides, glucosylceramides, galactosylceracides, and monoacyl phospholipids are combined together in cosmetics and applied to the skin, the results are higher than when ceramides, glucosylceramides, and galactosylceracides are used alone. It has a strong affinity for the surface of the skin and the stratum corneum, the outermost layer of the skin, making their structure denser and reducing moisture 81 inside the skin.
It has been found that it is highly effective in regulating the skin's skin temperature, enhancing the skin's heat-retaining function, and improving rough skin.

これらの作用メカニズムにより、セラミド、グルコシル
セラ稟ド、ガラクトシルセラごド及びモノアシル型リン
脂質とを配合してなる本発明の皮膚化粧料は、水分保持
機能を亢進することにより、乾燥皮膚を改善し、あるい
は皮膚を健常な状態に保持してその老化を防ぎ、皮膚に
iW K8性(しっとり感)、柔軟性(滑らか感)、弾
力性及び艶を与える美肌効果を有することを見出し本発
明を完成するに至った。
Due to these mechanisms of action, the skin cosmetic of the present invention, which is formulated with ceramide, glucosylcerargonide, galactosylceragode, and monoacyl-type phospholipid, improves dry skin by enhancing the moisture retention function. The present invention has been completed by discovering that it has a skin beautifying effect that maintains the skin in a healthy state and prevents its aging, giving the skin iW K8 properties (moist feeling), flexibility (smooth feeling), elasticity, and luster. I ended up doing it.

すなわち本発明は、下記の一般式(1)%式% 又は下記の一般式(2) CI(、−O1+ CI+−0−R・・・・・・・・・(2)CI(、−X (上記の式中で、Rは−CC+Jss、又はI −CC15H3+ 1 Xは Hz CH。That is, the present invention is based on the following general formula (1)% formula% Or the following general formula (2) CI(, -O1+ CI+-0-R・・・・・・・・・(2) CI(,-X (In the above formula, R is -CC+Jss, or I -CC15H3+ 1 X is Hz CH.

N・ (CHi)3 e 1 0−P −0−c++、  −co、 −NeH,又は
0θ で表わされる化合物の少なくとも一つと、セラミド、グ
ルコシルセラミド、ガラクトシルセラミドより選ばれた
少なくとも一種とを含有してなる皮膚化粧料である。
Contains at least one compound represented by N.(CHi)3e10-P-0-c++, -co, -NeH, or 0θ and at least one selected from ceramide, glucosylceramide, and galactosylceramide. It is a skin cosmetic product.

本発明の皮膚化粧料の場合、従来の皮膚化を料のごとく
前記の皮膚湿潤剤、皮膚柔軟剤を多量に配合する必要が
なく、また、皮膚の正常な生理機能が妨げられるおそれ
がない。
In the case of the skin cosmetics of the present invention, there is no need to incorporate large amounts of the above-mentioned skin moisturizers and skin softeners as in conventional skin preparations, and there is no risk of interfering with the normal physiological functions of the skin.

本発明における前記一般式fi+および(2)で表わさ
れる化合物、すなわちモノー〇−アシルー3グリセリル
ホスホリルコリン、モノー〇−アシルー3グリセリルホ
スホリルエタノールアミン、モノO−アシルー3−グリ
セリルホスホリルイノシトール自体は公知である。一般
式filで表わされる化合物としては、1−バルミトイ
ル−3−グリセリルホスホリンコリン、1−ステアロイ
ル−3グリセリルホスホリルコリン、1−バルミトイル
3−グリセリルホスホリルエタノールアミン1−ステア
ロイル−3−グリセリルホスホリルエタノールアミン1
1−バルミトイル−3−グリセリルホスホリルイノシト
ール、1−ステアロイル3 グリセリルホスホリルイノ
シトールが挙げられる。一般式(2)で表わされる化合
物としては、2−バルミトイル−3−グリセリルホスホ
リルコノン、2−ステアロイル−3−グリセリルホスホ
リルコリン、2−バルミトイル−3−グリセリルホスホ
リルエタノ−ルアaン、2−ステアロイル3−グリセリ
ルホスホリルエタノールアミン。
The compounds represented by the general formulas fi+ and (2) in the present invention, ie, mono-0-acyl-3-glycerylphosphorylcholine, mono-0-acyl-3-glycerylphosphorylethanolamine, and mono-O-acyl-3-glycerylphosphorylinositol are themselves known. Compounds represented by the general formula fil include 1-valmitoyl-3-glycerylphosphorylcholine, 1-stearoyl-3-glycerylphosphorylcholine, 1-valmitoyl-3-glycerylphosphorylethanolamine 1-stearoyl-3-glycerylphosphorylethanolamine 1
Examples include 1-valmitoyl-3-glycerylphosphorylinositol and 1-stearoyl 3-glycerylphosphorylinositol. Examples of the compound represented by the general formula (2) include 2-valmitoyl-3-glycerylphosphorylconone, 2-stearoyl-3-glycerylphosphorylcholine, 2-valmitoyl-3-glycerylphosphorylethanolan, 2-stearoyl 3- Glycerylphosphorylethanolamine.

2−バルミトイル−3−グリセリルホスホリルイノシト
ール、2−ステアロイル−3−グリセリルホスホリルイ
ノシトールが挙げられる。
Examples include 2-valmitoyl-3-glycerylphosphorylinositol and 2-stearoyl-3-glycerylphosphorylinositol.

前記の一般式10および(2)で表わされる化合物は例
えば、卵黄より得られるホスファチジルコリン。
Examples of the compounds represented by the above general formulas 10 and (2) include phosphatidylcholine obtained from egg yolk.

ホスファチジルエタノ−ルアξンまたはホスファチジル
イノシトールを原料として、蛇毒ホスホリパーゼまたは
豚すい臓抽出酔素のバンクレアチンで処理し、高速液体
クロマトグラフィーにより分画して得られる。あるいは
、特開昭61171407号公報、特開昭61−180
305号公報5特開昭61−210016号公報に記載
されている化学的合成法によっても得られる。
It is obtained by using phosphatidylethanolane or phosphatidylinositol as a raw material, treating it with snake venom phospholipase or vancreatin, an intoxicant extracted from pig pancreas, and fractionating it by high performance liquid chromatography. Or, JP-A-61171407, JP-A-61-180
It can also be obtained by the chemical synthesis method described in JP-A No. 305-5 and JP-A-61-210016.

本発明における前記の一般式(1)および(2)で表わ
される化合物は、一種又は二種以上を組合せて使用され
る。
The compounds represented by the above general formulas (1) and (2) in the present invention may be used alone or in combination of two or more.

本発明に用いるセラミド、グルコシルセラミド。Ceramide and glucosylceramide used in the present invention.

ガラクトシルセラミドは、人、豚、牛、馬、羊などの呻
乳動物の表皮に微量存在する化合物であって〔バイオケ
ミストリー、アンド、フィジオロジ、オブ、ザ、スキン
、第363頁〜第381頁(Biochemistey
 and I’hysioligy of the 5
kinOxford [In1versity Pre
ss、 Inc、 1983 Ne1i York )
ジャーナル、オブ、リピフド、リサーチ第24S198
3年第181頁〜第140頁(Journal of↓ Lipid Re5erch Volume  24 
、 1983 )等を参照〕、これらの動物表皮より通
常の抽出方法にて得ることが可能である0本発明におい
ては、特開昭61−271205号公報や生化学実験書
〔脂質の生化学、生化学実験講座、第3巻、20〜21
頁、1974年、日本生化学全編、東京化学同人〕に記
載されている製造方法により得られるセラξド、グルコ
シルセラミド、ガラクトシルセラミドを用いることがで
きる。
Galactosylceramide is a compound that exists in trace amounts in the epidermis of mammals such as humans, pigs, cows, horses, and sheep [Biochemistry and Physiology of the Skin, pp. 363-381 ( Biochemistry
and I'hysioligy of the 5
kinOxford [In1versity Pre
ss, Inc., 1983 Ne1i York)
Journal of, Lipifed, Research No. 24S198
3rd year, pages 181-140 (Journal of↓ Lipid Re5erch Volume 24
, 1983), etc.], and can be obtained from the epidermis of these animals by a conventional extraction method. Biochemistry Experiment Course, Volume 3, 20-21
It is possible to use ceraξ-d, glucosylceramide, and galactosylceramide obtained by the production method described in 1974, Nippon Biochemical Complete Edition, Tokyo Kagaku Dojin.

上記した式(1)および(2)で表わされる化合物の配
合量、および前記セラξド、グルコシルセラミド。
The amount of the compound represented by the above formulas (1) and (2), and the above-mentioned ceramide and glucosylceramide.

ガラクトシルセラミドの配合量は、化粧品の総量を基準
として、夫々大略0.01〜5wt%が好ましい0式(
1)および(2)の化合物またはセラξド、グルコシル
セラミド、ガラクトシルセラミドの一方でも上記量より
少ないと効果が充分に達成されない、また、これらが上
記量を越えてもその増加分に見合った効果の向上は望め
ない。
The blending amount of galactosylceramide is preferably approximately 0.01 to 5 wt%, respectively, based on the total amount of the cosmetic.
If the amount of any of the compounds of 1) and (2) or cera ξ-do, glucosylceramide, or galactosylceramide is less than the above amount, the effect will not be fully achieved, and even if these amounts exceed the above amount, the effect will be commensurate with the increased amount. cannot be expected to improve.

本発明の皮膚化粧料には、必要に応して色素。The skin cosmetics of the present invention may optionally contain pigments.

香料、防腐剤、界面活性剤、顔料、酸化防止剤等を本発
明の目的を達成する範囲内で適宜配合することができる
Flavors, preservatives, surfactants, pigments, antioxidants, and the like may be added as appropriate within the scope of achieving the object of the present invention.

本発明の皮膚化粧料は、例えばクリーム類、乳液類、ロ
ーション類、パンク類、美容液等に適用することができ
る。
The skin cosmetics of the present invention can be applied to, for example, creams, emulsions, lotions, blowouts, beauty serums, and the like.

〔実施例〕〔Example〕

以下、実施例について説明する。 Examples will be described below.

なお、実施例中で使用したセラ〔ド、グルコシルセラミ
ド、ガラクトシルセラミドは以下の方法によって得たも
のを用いた。
The ceramide, glucosylceramide, and galactosylceramide used in the examples were obtained by the following method.

(ガラクトシルセラミドの製造) 牛脳を細切後、アセトンを添加し、ポリI・ロンにてホ
モジネートを調製した。不溶物を濾別後、クローホルム
−メタノール(2: 1)を添加、夜放置後、抽出液を
減圧乾固した。ついて、冷アセトンに抽出液を懸濁させ
、4℃−夜放置後、沈渣を分離した。さらに冷エーテル
にて同様の操作を行い沈渣を得た。沈渣より、ケイ酸カ
ラムクロマトクラフィー(溶媒−クロロホルム:メタノ
ール=2:1)によりガラクトシルセラミドを分離して
得た。
(Manufacture of galactosylceramide) After cutting the bovine brain into small pieces, acetone was added, and a homogenate was prepared using polyIron. After filtering off insoluble matter, chloroform-methanol (2:1) was added, and after standing overnight, the extract was dried under reduced pressure. Then, the extract was suspended in cold acetone and left to stand at 4°C overnight, and then the precipitate was separated. Further, the same operation was performed using cold ether to obtain a precipitate. Galactosylceramide was separated from the precipitate by silicic acid column chromatography (solvent-chloroform:methanol=2:1).

(グルコシルセラミドの製造) 上記(ガラクトシルセラミドの製造)中、牛脳を牛牌臓
に変えるほかは全く同様にしてグルコシルセラミドを分
離して得た。
(Manufacture of glucosylceramide) Glucosylceramide was separated and obtained in exactly the same manner as described above (manufacture of galactosylceramide) except that bovine spleen was used instead of bovine brain.

(セラミドの製造) 上記(ガラクトシルセラミドの製造)中、ガラクトシル
セラミドを分離後の同じケイ酸カラムクロマトグラフィ
ーにて、溶媒をクロロホルム:ヌクノール−l:1にす
ることによってスフィンゴミエリンを分離した。これを
エーテル−エタノール(98:2)に溶解後、100m
M)リス−塩酸緩衝液(20mM塩化カルシウム含有)
及びホスホリパーゼC(ウェルシュ菌由来、Sigma
社製)を加え、30℃3時間振とうさせた。その後、ク
ロロホルム−メタノール(2: 1)を添加し撹拌、遠
心し、下層を分離し減圧乾固した。乾固物よりケイ酸カ
ラムクロマトグラフィー(溶媒電りロロホルム:メタノ
ール=lI)によりセラミドを分離した。
(Manufacture of ceramide) In the above (manufacture of galactosylceramide), sphingomyelin was separated by using the same silicic acid column chromatography after separating galactosylceramide by changing the solvent to chloroform:Nuknol-1:1. After dissolving this in ether-ethanol (98:2), 100 m
M) Lis-HCl buffer (containing 20mM calcium chloride)
and phospholipase C (derived from Clostridium perfringens, Sigma
(manufactured by Co., Ltd.) was added thereto, and the mixture was shaken at 30°C for 3 hours. Thereafter, chloroform-methanol (2:1) was added, stirred and centrifuged, and the lower layer was separated and dried under reduced pressure. Ceramide was separated from the dried product by silicic acid column chromatography (solvent: chloroform:methanol=1I).

また、本発明の皮膚化粧料の皮膚老化防止効果を評価す
るために用いた荒肌改善効果試験、角質改善効果試験、
保湿効果試験(T W L、 (a低減率)美肌効果試
験(実用テスト)は下記の通りである。
In addition, rough skin improvement effect test, keratin improvement effect test, used to evaluate the skin aging prevention effect of the skin cosmetics of the present invention,
The moisturizing effect test (T W L, (a reduction rate)) skin beautifying effect test (practical test) is as follows.

+1+  美肌改善効果試験 下脚に荒れ肌を有する中高年被験者20名を対象として
4週間連yE塗布効果を調べた。被験者の左側下脚試験
部位に1日1回約1gの試料を塗布し、試験開始前及び
終了後の皮膚の状雇を下記の判定基準により肉眼判定し
た。右側下脚は試料を塗布せず対照とした。
+1+ Skin Improving Effect Test The effect of applying yE for 4 weeks was investigated on 20 middle-aged and elderly subjects who had rough skin on their lower legs. Approximately 1 g of the sample was applied to the test site of the left lower leg of the subject once a day, and the condition of the skin before and after the test was visually judged according to the following criteria. No sample was applied to the right lower leg, which served as a control.

皮膚乾燥度の判定基準 :正常 ±  :軽微乾燥、落屑なし +  :乾燥、落屑軽度 ++:乾燥、落屑中等度 +++:乾燥、落屑顕著 試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば、十−−
1千十−±)を有効、1段階改善された場合をやや有効
、変化がなかった場合を無効とした。試験結果は有効、
やや有効となった被験者の人数で示した。
Judgment criteria for skin dryness: Normal±: Slight dryness, no flaking+: Mild dryness, flaking++: Moderate dryness, flaking+++: Significant dryness, flaking Comparing the judgment results of the test site and control site before and after the test, skin If the dryness has improved by two or more levels (for example, 10--
1,000-±) was considered effective, one level improvement was considered somewhat effective, and no change was considered invalid. Test results are valid;
It is shown by the number of subjects who were somewhat effective.

(2)  角質層改善効果試験 前述の荒肌改善効果試験開始前及び終了後の被験者皮膚
にスコソチテープにチバンメンディングテーブ)を接着
し、これを#JJ 離した時テープに付着した角質細胞
の状態を走査型電子顕微鏡によって詳細に調べ、下記の
基準によって皮膚角質細胞抗剥離性を解析し、角質層改
善効果〈角質細胞抗2II離性増大効果)を求めた。
(2) Stratum corneum improvement effect test Before and after the start and end of the rough skin improvement effect test described above, Scosochi tape and Tiban mending tape) were adhered to the subject's skin, and #JJ was removed to determine the state of the corneocytes attached to the tape. was examined in detail using a scanning electron microscope, and the skin corneocyte anti-exfoliation property was analyzed according to the following criteria to determine the stratum corneum improving effect (keratin cell anti-2II desquamation increasing effect).

角質層改善効果の判定基準 評価点1ニスケールを認めず 2:小スケール点在 3:小〜中スゲール顕著 4:大スケール顕著 評価は、4週間達Vt塗布後の試験部位の評価点と対照
部位のそれとの差が2点以上の場合を有効、1点の場合
をやや有効、0点の場合を有効とした。
Judgment criteria for the effect of improving the stratum corneum Evaluation points 1: No scales observed 2: Small scales dotted 3: Small to medium scales noticeable 4: Large scales noticeable The evaluation is based on the evaluation points of the test site after 4 weeks of Vt application and the control site. It was considered valid if the difference was 2 or more points, slightly valid if it was 1 point, and valid if it was 0 points.

試験結果は、20人中有効、やや有効となった被験者の
人数で示した。
The test results are shown in terms of the number of subjects out of 20 who found the drug to be effective or somewhat effective.

(3)  保温効果試験(TWL値低減率)前述の荒肌
改善効果試験開始前及び終了後の被験者皮膚を対象とし
て4週間連5Fjt塗布前及び塗布後のTWL値及びT
WL値の低減率(水分保持機能亢進効果)を下記の如く
算出して、保湿効果を調べた。
(3) Heat retention effect test (TWL value reduction rate) TWL value and T before and after application of 5Fjt for 4 weeks consecutively on the subject's skin before and after the start and end of the rough skin improvement effect test described above
The reduction rate of WL value (moisture retention function enhancement effect) was calculated as follows to examine the moisturizing effect.

■TWL値 密閉した皮表上の空気の一定時間内の温度変化を電気抵
抗にて測定する方法を用いた。
■TWL value A method was used to measure the temperature change of the air above the sealed skin surface over a certain period of time using electrical resistance.

即ち、被試験者の皮表を測定用セルで密閉し、セルに強
制乾燥した空気を通気してセル内を乾燥空気で充分置換
した後、乾燥空気の通気を停止してその時点でのセル内
の相対湿度RH5(%)を求め、次いで10分間放置し
て再びセル内の相対湿度RHIO(%)を測定し、この
時の温度変化から下記の式によりTWL値(mg/cm
”/hr)を算出した。
That is, the test subject's skin surface is sealed in a measurement cell, forced dry air is vented into the cell to sufficiently replace the inside of the cell with dry air, and then the ventilation of dry air is stopped and the cell is closed at that point. The relative humidity RH5 (%) in the cell is determined, and then the relative humidity RHIO (%) in the cell is measured again after being left for 10 minutes. From the temperature change at this time, the TWL value (mg/cm
”/hr) was calculated.

但し、Dt:測定温度下(t ’c)での空気中の飽和
水蒸気の密度(mg/i’) ■ =セルの容積(1) S :測定面積(cm”) ■TWL値の低域率 T W L値の低減率は、試料塗布前後のTWL値、T
WLA及びTWLBを下記の式に代入して算出した。
However, Dt: Density of saturated water vapor in the air at measurement temperature (t'c) (mg/i') ■ = Volume of cell (1) S: Measurement area (cm'') ■ Low range rate of TWL value The reduction rate of T W L value is the TWL value before and after sample application, T
It was calculated by substituting WLA and TWLB into the following formula.

TWL値低減率= (1,−TWLB /TWLA ) X 100 (%
)TWLA  :試料塗布前のTWL値 TWLB  :試料塗布後のTWL値 TWL値の低減率が20%以上の場合を「有効」、低減
率が20%未満の場合を「無効」とした、試験結果は、
20人中の「有効」であった被験者の人数で表示した。
TWL value reduction rate = (1,-TWLB /TWLA) x 100 (%
) TWLA: TWL value before sample application TWLB: TWL value after sample application Test results where the reduction rate of TWL value is 20% or more as “valid”, and the case where the reduction rate is less than 20% as “invalid” teeth,
The number of subjects who were "effective" out of 20 was displayed.

(4)  美肌効果試験(実用テスト)荒れ肌、小国、
乾燥肌等を訴える女子被験者(35〜55才)20人に
試料を1日2回(朝・り〉連続3ケ月後の効果を評価し
た。試験結果は、皮膚の湿潤性、平滑性1弾力性の各項
目に対して、「皮膚に潤いが生じた」、「皮膚が滑らか
になったj、「皮膚に張りが生した」と回答した人数で
示した。
(4) Beautiful skin effect test (practical test) rough skin, small country,
Samples were given to 20 female subjects (35 to 55 years old) who complained of dry skin etc. twice a day (morning and morning) and the effects were evaluated after 3 consecutive months.The test results were as follows: skin moisture, smoothness, elasticity, For each gender item, the number of respondents who answered ``My skin became moist,'' ``My skin became smooth,'' and ``My skin became taut.''

実施例1〜4.比較例1 スキンクリーム下記の&ll
戒にて、スキンクリームを調製し、前(1) m威 溶解したものを混合しホモミキサーにて分散した。
Examples 1-4. Comparative Example 1 Skin cream below &ll
A skin cream was prepared at Kai, and the ingredients dissolved in the previous step (1) were mixed and dispersed using a homomixer.

次いで撹拌しつつ30℃まで冷却して各スキンクリーム
を調製した。
Next, each skin cream was prepared by cooling to 30° C. while stirring.

(3)  特性 第1表に示す如く、本発明の皮膚化粧料である実施例1
〜4のスキンクリームは、比較例1と比較して緒特性の
全てに亘って優れており、配合特性に於いても異常は認
められなかった。
(3) Properties As shown in Table 1, Example 1 is a skin cosmetic of the present invention.
The skin creams No. 4 to 4 were superior to Comparative Example 1 in all of the skin properties, and no abnormality was observed in the blending properties.

実施例5〜8、比較例2 スキンミルク下記の組成にて
、スキンミルクを!I!製し、前記+21  !II製
法 (C)成分中のセラミド、グルコシルセラミド。
Examples 5 to 8, Comparative Example 2 Skin milk Skin milk with the following composition! I! Made and said +21! Ceramide and glucosylceramide in the II production method (C) component.

ガラクトシルセラミドを予め(A)成分中に80℃にて
加温溶解した後、これに、(B)成分及び(C)成分中
のモノアシル型リン脂質を80℃にて加温11 &II或 ものを混合し、ホモミキサーにて分散した6次いで撹拌
しつつ30℃まで冷却して各スキンミルクを調製した。
After preliminarily dissolving galactosylceramide in component (A) by heating at 80°C, add monoacyl phospholipid in component (B) and component (C) to this by heating at 80°C. The mixture was mixed and dispersed in a homomixer, and then cooled to 30° C. with stirring to prepare each skin milk.

(3)  特性 各スキンミルクの諸試験を実施した結果を第1表右欄に
記載した。
(3) Characteristics The results of various tests conducted on each skin milk are listed in the right column of Table 1.

比較例2の1−バルミトイル−3−グリセリルホスホリ
ルコリン未配合化粧料と比較して、1−バルミトイル−
3−グリセリルホスホリルコリンを配合した実施例5〜
8の本発明の皮膚化粧料は+21 11殻法 セラミド、グルコシルセラミド、ガラクトシルセラミド
を予め(A)成分中に80℃にて溶解した後、これに、
(B)成分を80℃にて加温溶解した〔発明の効果〕 以上記載の如く、本発明の皮膚化粧料は、皮膚の水分保
持機能を冗進し、皮膚を健常な状態に保持し、或いは修
復して、かつ美肌作用を有する優れた皮膚化粧料を提供
することが明らかである。
Compared to the cosmetic containing no 1-valmitoyl-3-glycerylphosphorylcholine of Comparative Example 2, 1-valmitoyl-3-glycerylphosphorylcholine was
Example 5 containing 3-glycerylphosphorylcholine
The skin cosmetic of the present invention of No. 8 is prepared by dissolving +21 11 shell method ceramide, glucosylceramide, and galactosylceramide in component (A) at 80°C, and then adding
Component (B) was dissolved by heating at 80° C. [Effects of the Invention] As described above, the skin cosmetic of the present invention enhances the moisture retention function of the skin, maintains the skin in a healthy state, It is clear that it is possible to provide an excellent skin cosmetic product that can repair or repair the skin and have beautifying effects.

Claims (1)

【特許請求の範囲】 下記の一般式(1) ▲数式、化学式、表等があります▼・・・・・・・・・
(1) 又は下記の一般式(2) ▲数式、化学式、表等があります▼・・・・・・・・・
(2) (上記の式中で、Rは▲数式、化学式、表等があります
▼、又は ▲数式、化学式、表等があります▼ Xは▲数式、化学式、表等があります▼ ▲数式、化学式、表等があります▼又は ▲数式、化学式、表等があります▼である) で表わされる化合物の少なくとも一つと、セラミド、グ
ルコシルセラミド、ガラクトシルセラミドより選ばれた
少なくとも一種とを含有してなる皮膚化粧料。
[Claims] The following general formula (1) ▲There are mathematical formulas, chemical formulas, tables, etc.▼・・・・・・・・・
(1) Or the following general formula (2) ▲There are mathematical formulas, chemical formulas, tables, etc.▼・・・・・・・・・
(2) (In the above formula, R is ▲ has a mathematical formula, chemical formula, table, etc. ▼, or ▲ has a mathematical formula, chemical formula, table, etc. ▼ X is ▲ has a mathematical formula, chemical formula, table, etc. ▼ ▲ mathematical formula, chemical formula , tables, etc. ▼ or ▲ mathematical formulas, chemical formulas, tables, etc. ▼) and at least one compound selected from ceramide, glucosylceramide, and galactosylceramide. fee.
JP20366989A 1989-08-04 1989-08-04 Dermal cosmetic Pending JPH0366604A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20366989A JPH0366604A (en) 1989-08-04 1989-08-04 Dermal cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20366989A JPH0366604A (en) 1989-08-04 1989-08-04 Dermal cosmetic

Publications (1)

Publication Number Publication Date
JPH0366604A true JPH0366604A (en) 1991-03-22

Family

ID=16477894

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20366989A Pending JPH0366604A (en) 1989-08-04 1989-08-04 Dermal cosmetic

Country Status (1)

Country Link
JP (1) JPH0366604A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06157283A (en) * 1992-07-24 1994-06-03 Unilever Nv Use of cosmetics composition
WO1995035091A1 (en) * 1994-06-21 1995-12-28 Institute For Advanced Skin Research Inc. Skin activator having glycosaminoglycan production accelerator activity
US5565439A (en) * 1992-11-24 1996-10-15 The Procter & Gamble Company Methods of using lysophosphatidic acid for treating hyperproliferative conditions
JPH10192686A (en) * 1996-12-27 1998-07-28 Pigeon Corp Solubilizer for galactosylceramide, solubilized galactosylceramide composition, solubilization of galactosylceramide, and galactosylceramide-containing oily agent
KR100333488B1 (en) * 1999-12-28 2002-04-25 김형국 Apparatus for discharging sediment with device for smashing the sediment
EP1066816A4 (en) * 1998-03-31 2003-10-29 Shiseido Co Ltd Agents promoting laminin production in skin cells
JP2006273747A (en) * 2005-03-29 2006-10-12 Kose Corp O/w/o type emulsion cosmetic
JP2007001950A (en) * 2005-06-27 2007-01-11 Pola Chem Ind Inc Ceramide-containing skin external preparation
WO2022231448A1 (en) * 2021-04-30 2022-11-03 Carbocode S.A. Topical compositions comprising (glyco)sphingolipids and/or (glyco)ceramides

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61112007A (en) * 1984-11-05 1986-05-30 Kanebo Ltd Solubilized water-based clear cosmetic
JPS61176511A (en) * 1985-01-30 1986-08-08 Kanebo Ltd Solubilized water-based clear cosmetic
JPS61183207A (en) * 1985-02-09 1986-08-15 Kanebo Ltd Solubilized water-based clear cosmetic
JPS61271205A (en) * 1985-05-24 1986-12-01 Kanebo Ltd Skin cosmetic
JPS61291514A (en) * 1985-06-19 1986-12-22 Kanebo Ltd Solubilized water-based clean cosmetic
JPS63192703A (en) * 1987-02-04 1988-08-10 Kao Corp External agent for skin
JPS63255212A (en) * 1987-04-13 1988-10-21 Kanebo Ltd Skin cosmetic

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61112007A (en) * 1984-11-05 1986-05-30 Kanebo Ltd Solubilized water-based clear cosmetic
JPS61176511A (en) * 1985-01-30 1986-08-08 Kanebo Ltd Solubilized water-based clear cosmetic
JPS61183207A (en) * 1985-02-09 1986-08-15 Kanebo Ltd Solubilized water-based clear cosmetic
JPS61271205A (en) * 1985-05-24 1986-12-01 Kanebo Ltd Skin cosmetic
JPS61291514A (en) * 1985-06-19 1986-12-22 Kanebo Ltd Solubilized water-based clean cosmetic
JPS63192703A (en) * 1987-02-04 1988-08-10 Kao Corp External agent for skin
JPS63255212A (en) * 1987-04-13 1988-10-21 Kanebo Ltd Skin cosmetic

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06157283A (en) * 1992-07-24 1994-06-03 Unilever Nv Use of cosmetics composition
US5565439A (en) * 1992-11-24 1996-10-15 The Procter & Gamble Company Methods of using lysophosphatidic acid for treating hyperproliferative conditions
US6019989A (en) * 1994-06-21 2000-02-01 Institute For Advanced Skin Research Inc. Skin activator with glycosaminoglycan production-accelerating effect
WO1995035091A1 (en) * 1994-06-21 1995-12-28 Institute For Advanced Skin Research Inc. Skin activator having glycosaminoglycan production accelerator activity
WO1995035090A1 (en) * 1994-06-21 1995-12-28 Institute For Advanced Skin Research Inc. Skin activator having glycosaminoglycan production accelerator activity
WO1995035092A1 (en) * 1994-06-21 1995-12-28 Institute For Advanced Skin Research Inc. Skin activator having glycosaminoglycan production accelerator activity
US5723136A (en) * 1994-06-21 1998-03-03 Institute For Advanced Skin Research, Inc. Skin activator with glycosaminoglycan production-accelerating effect
US5849309A (en) * 1994-06-21 1998-12-15 Institute For Advanced Skin Research Inc. Skin activator with glycosaminoglycan production-accelerating effect
JPH10192686A (en) * 1996-12-27 1998-07-28 Pigeon Corp Solubilizer for galactosylceramide, solubilized galactosylceramide composition, solubilization of galactosylceramide, and galactosylceramide-containing oily agent
EP1066816A4 (en) * 1998-03-31 2003-10-29 Shiseido Co Ltd Agents promoting laminin production in skin cells
KR100333488B1 (en) * 1999-12-28 2002-04-25 김형국 Apparatus for discharging sediment with device for smashing the sediment
JP2006273747A (en) * 2005-03-29 2006-10-12 Kose Corp O/w/o type emulsion cosmetic
JP2007001950A (en) * 2005-06-27 2007-01-11 Pola Chem Ind Inc Ceramide-containing skin external preparation
WO2022231448A1 (en) * 2021-04-30 2022-11-03 Carbocode S.A. Topical compositions comprising (glyco)sphingolipids and/or (glyco)ceramides

Similar Documents

Publication Publication Date Title
KR101404968B1 (en) Cosmetic composition containing liquid crystal complex for enhancing moisturizing effect on the skin and for reducing skin roughness
JP3383496B2 (en) Method for producing liquid crystal emulsion and liquid crystal emulsion composition obtained by the method
JPS61271205A (en) Skin cosmetic
JPH0366604A (en) Dermal cosmetic
EP1342473B1 (en) Topical application of vitamin E esters
JP2572730B2 (en) Skin cosmetics
JPS61289013A (en) Skin external agent
JPH07187987A (en) Skin cosmetic
JPS63150209A (en) Skin cosmetic
KR102036141B1 (en) Cosmetic Composition Containing Cholesteric Liquid Crystal With Dual Capsule Process
JP2511820B2 (en) Skin cosmetics
KR20130042918A (en) Composition for balacing sebum and moisture of skin and cosmetic compsition comprising it
JPH10175843A (en) Cosmetic for skin
KR101359947B1 (en) Cosmetic composition containing moisturizing complex for moisturizing the skin
JPS6281307A (en) Skin cosmetic
JP4046426B2 (en) Ceramide derivative and skin cosmetic containing the same
JP3220275B2 (en) Wrinkle improver
KR100370455B1 (en) Cosmetic composition for dry skin of atopic dermatitis and recovery of disrupted skin barrier
JPS60163806A (en) Skin pharmaceutical for external use
JPH0374316A (en) Humectant
JPS62226910A (en) Skin cosmetic
KR100787312B1 (en) Cosmetic composition for moisturizing effect on the skin containing the mixture of jasmine extract, arnica extract and yarrow extract
KR100439595B1 (en) Tocopherol-containing Ceramide Liquid Crystal Capsule, Emulsion thereof and Cosmetic comprising the same
JPH0764701B2 (en) Skin cosmetics
KR19990050828A (en) A stick type lip cosmetic composition containing a retinoid